Abstract
Malignant struma ovarii is a very rare disease and, therefore, there is neither common agreement on treatment regimens nor sufficient follow-up experience. We present a case of a 49-year-old woman with malignant struma ovarii of the follicular type, who received ablative radioiodine treatment after thyroidectomy and surgical removal of the primary tumour. During followup examinations an increasing thyroglobulin level was found, caused by a tumour relapse with suspected urinary bladder infiltration on CT and proven uptake of radioiodine on whole-body scanning with iodine-131. After administration of 6 GBq131I, complete tumour regression was achieved with no evidence of a new relapse during a 30-month follow-up period. Correspondingly, repeated thyroglobulin measurements were all negative. This case demonstrates the benefit of combined surgical and radioiodine treatment of malignant struma ovarii for both monitoring and therapy of relapse or metastases; thus, the same therapeutic regimen as is employed in primary differentiated thyroid carcinoma may be recommended.
Similar content being viewed by others
References
Ayhan A, Yanik F, Tuncer R, Tuncer ZS, Ruacan S. Struma ovarii.Int J Gynaecol Obstet 1993; 42: 143–146.
Thomas RD, Batty VB. Metastatic malignant struma ovarii: two case reports.Clin Nucl Med 1992; 17: 577–578.
Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases.Int J Gynecol Pathol 1993; 12: 333–343.
Zakhem A, Aftimos G, Kreidy R, Salem P. Malignant struma ovarii: report of two cases and selected review of the literature.J Surg Oncol 1990; 43: 61–65.
Wierrani F, Gill F, Grünberger W. Struma ovarii maligna.Geburtshilfe Frauenheilkd 1992; 52: 499–500.
Mazzaferri EL. Radioiodine and other treatment and outcomes. In: Braverman LE, Utiger RD, eds.The thyroid. A fundamental and clinical text. Philadelphia: Lippincott; 1991: 1138–1165.
Pardo-Mindan FJ, Vazquez JJ. Malignant struma ovarii. Light and electron microscopic study.Cancer 1983; 51: 337–343.
Willemse PHB, Oosterhuis JW, Aalders JG, Piers DA, Sleijfer DT, Vermey A, Doorenbos H. Malignant struma ovarii treated by ovariectomy, thyroidectomy and 131-I administration.Cancer 1987; 60: 178–182.
McDougall R, Krasne D, Hanbery W, Collins JA. Metastatic malignant struma ovarii presenting as paraparesis from a spinal metastasis.J Nucl Med 1989; 30: 407–411.
Kroiss A, Janata K, Grünberger W, Gabriel C, Dinstl K. Maligne Struma ovarii.Schilddrüse 1991: Therapie der Struma. 10. Konferenz über die menschliche Schilddrüse — Heidelberg. Berlin: de Gruyter; 1992: 467–470.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brenner, W., Bohuslavizki, K.H., Wolf, H. et al. Radiotherapy with iodine-131 in recurrent malignant struma ovarii. Eur J Nucl Med 23, 91–94 (1996). https://doi.org/10.1007/BF01736995
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01736995